ILEP 2026 · Warsaw

Scientific Programme

Explore the scientific programme of the 3rd Congress of the International Lipid Expert Panel. Two days of lectures, discussions, expert sessions and international collaboration.

⌕
12:00
12:15
Opening

Opening Ceremony of the 3rd Congress of the International Lipid Expert Panel (ILEP)

2025 ILEP Brief Summary: Prof. Maciej Banach, President, ILEP
Welcome Messages: Prof. Jagat Narula, President, WHF; Prof. Michael D. Shapiro, President, ASPC

Chairs: Prof. Maciej Banach (ILEP, Poland), Prof. Michael D. Shapiro (ASPC, USA), Prof. Prabhakaran Dorairaj (WHF, India)
12:15
13:15
Plenary

PLENARY SESSION – Keynote Lectures

Chairs: Prof. Handrean Soran (UK), Prof. Dragos Vinereanu (Romania)
12:15–12:35

New 2026 ACC/AHA Lipid Guidelines – What Has Changed? Enhancing Clinical Practice in Diagnosis and Therapy.

Prof. Michael D. Shapiro · ASPC, USA
12:35–12:55

Should ethnicity decide the ideal lipid biomarker across populations?

Prof. Prabhakaran Dorairaj · WHF, India
12:45–13:00

Regression of Atherosclerotic Plaque: From Myth to Reality

Prof. Robert Gil · ESC, Poland
13:00–13:15 · Discussion
13:15
14:15
Session

Evidence-Based Lifestyle Strategies for Preventing Cardiovascular Disease

Chairs: Prof. Dan Gaita (Romania), Prof. Maciej Banach (Poland)
13:15–13:30

ILEP 2026 Physical Activity Recommendations — Integrating Step Counts into Routine Exercise.

Dr. Joanna Lewek · Poland
13:30–13:45

Dietary guidelines (2026) in lipid disorders and primary and secondary prevention of cardiovascular diseases.

Dr. Federica Fogacci · Italy
13:45–14:00

Ten Years On: Updated ILEP Consensus on Lipid-Lowering Nutraceuticals

Prof. Arrigo F.G. Cicero · Italy
14:00–14:15 · Discussion
14:15
15:15
Lunch
15:15
16:15
Session

The ILEP-SMILE Algorithm: Addressing Risk Modifiers and Nonadherence for Effective Prevention and Management

Chairs: Prof. Arrigo F.G. Cicero (Italy), Prof. Gustavs Latkovskis (Latvia)
15:15–15:30

Diabetes, Obesity, Metabolic Syndrome and SLD — 2026 Guideline for Prevention, Diagnosis and Management of Cardiovascular–Kidney–Metabolic (CKM) Syndrome

Prof. Niki Katsiki · Greece
15:30–15:45

Hypertriglyceridaemia as a multisystem disorder: From established knowledge to new frontiers.

Prof. Handrean Soran · UK
15:45–16:00

Improving Adherence and Lipid Outcomes in Dyslipidaemia with an Achievement-Oriented Patient Digital Support.

Prof. Margus Viigimaa · Estonia
16:00–16:15 · Discussion
16:15
17:15
Session

Don't Ignore Inflammation: Current Insights and Why the Story Continues

Chairs: Prof. Agata Bielecka-Dąbrowa (Poland), Prof. Niki Katsiki (Greece)
16:15–16:30

From Culprits to Clues: Immune Cells as Biomarkers in Atherosclerosis

Prof. Andreas Zirlik · Austria
16:30–16:45

CARDIO-INFLAME, POSEJDON, ZEUS - Inflammation Awareness, Prevalence and Clinical Relevance: 2026 Status and Perspectives.

Prof. Maciej Banach · Poland
16:45–17:00

Targeting Inflammation in Heart Failure: Mechanisms, Consequences, and Potential Treatments

Prof. Dragos Vinereanu · Romania
17:00–17:15 · Discussion
17:15
17:30
Coffee Break
17:30
19:30
Alliance

European Program for Prevention (EPP) and Central European Prevention Initiative (CEPI) Alliance

A platform for exchanging expertise to develop effective prevention programs across Central and Eastern Europe and beyond.

Chairs: Prof. Jacek Jozwiak (Poland), Prof. Andreas Zirlik (Austria)
17:30–17:45

Integrating Familial Hypercholesterolemia Care with SCORE2-driven Primary CVD Prevention: Lessons from Latvia

Prof. Gustavs Latkovskis · Latvia
17:45–18:00

Integrated Primary Prevention of Cardiovascular Disease in Lithuania: LitHiR Programme and FH Screening Strategies

Prof. Žaneta Petrulionienė · Lithuania
18:00–18:15

Kosovo FH Registry — Toward Earlier Diagnosis and Improved Cardiovascular Outcomes

Prof. Ibadete Bytyçi · Kosovo
18:15–18:30

Detecting Familial Hypercholesterolemia via Universal Pediatric Screening in Slovakia

Prof. Branislav Vohnout · Slovakia
18:30–18:45

Bleeding-Edge Prevention in Poland: Insights from My Health Data and the B101 Drug Program

Prof. Maciej Banach · Poland
18:45
19:30
Debate

Lipids and CVD Prevention - Awareness, Early Care, and System-Level Strategies: ILEP/WHF White Paper; Warsaw Call to Action: 10% Prevention Budget

Moderator: Prof. Maciej Banach (Poland)
Participants
Prof. Prabhakaran Dorairaj Prof. Gustavs Latkovskis Prof. Raimondas Kubilius Prof. Daniel Pella Prof. Zlatko Fras Prof. Robert Gil Prof. Margus Viigimaa Prof. Arman Postadzhiyan Prof. Richard Ceska
19:30 · End of the First Day
09:00
10:00
Opening Session

Lipids 2026 — Cutting-Edge: Genetic Insights, Novel Biomarkers, Advanced Imaging, and AI for Prevention

Chairs: Prof. Zlatko Fras (Slovenia), Prof. Tadeusz Osadnik (Poland)
09:00–09:15

Application of Proteo-Genomics in Cardiovascular Diseases: Insights from Cross-Ancestry Populations.

Prof. Mohsen Mazidi · UK
09:15–09:30

Imaging to Guide Initiation and Intensification of Lipid Therapy — Practical 2026 ILEP Guidance

Prof. Pierre Sabouret · France
09:30–09:45

From Models to Medicine: New Data on Digital Twins for Lipid Care

Prof. Carlos Escobar · Spain
09:45–10:00 · Discussion
10:00
11:00
Session

Cardiometabolic Disorders and Atherogenic Dyslipidemia — Two Sides of the Same Coin?

Chairs: Dr. Alexandr Ceasovschih (Romania), Prof. Pierre Sabouret (France)
10:00–10:15

Beyond Glucose: Cardiovascular Risk Underestimation in T1DM — A Clinician's View.

Prof. Delia Reurean-Pintilei · Romania
10:15–10:30

GLP-1 Agonists — Lipids, Inflammation, Obesity: Can Statin Lessons Guide Patient Selection?

Prof. Dan Gaita · Romania
10:30–10:45

Obesity and Heart Failure — Do New Therapies Break Established Paradigms?

Prof. Agata Bielecka-Dąbrowa · Poland
10:45–11:00 · Discussion
11:00
12:00
Session

Core Components of Effective Cardiovascular Prevention

Chairs: Prof. Krzysztof Dyrbuś (Poland), Prof. Carlos Escobar (Spain)
11:00–11:15

Combined Homocysteine and hs-Troponin Biomarkers in Subclinical MI and Premature ASCVD: Reborn or Dead - The Fate of Homocysteine in CVD Risk Assessment.

Prof. Dragan Djuric · Serbia
11:15–11:30

Why Polyvascular Patients Face Very High Cardiovascular Risk: Findings from CV-IMP.

Prof. Jacek Jozwiak · Poland
11:30–11:45

REVIELED Observational Study — Real-World Insights into Extreme CV Risk

Prof. Arman Postadzhiyan · Bulgaria
11:45–12:00 · Discussion
12:00
12:15
Coffee Break
12:15
13:15
Session

Lp(a) in CVD Risk: Current Knowledge, Predictive Power, and Expectations — One Month Ahead of HORIZON-Lp(a)

Chairs: Prof. Tadeusz Osadnik (Poland), Dr. Federica Fogacci (Italy)
12:15–12:30

2026 PoLA vs. ESC and AHA/ACC on Elevated Lp(a): Practical Implications for Diagnosis and Management.

Dr. Bozena Sosnowska · Poland
12:30–12:45

Lp(a) and Long-Term Cardiovascular Outcomes Following Upfront Combination Lipid Therapy: Real-World Analysis.

Dr. Kunal Mahajan · India
12:45–13:00

Lp(a) Evidence Ahead of HORIZON-Lp(a): Game Changer for CVD or HDL-C-Like Setback?

Prof. Maciej Banach · Poland
13:00–13:15 · Discussion
13:15
14:15
Session

Overcoming Barriers: Lipid Management Approaches for High-Risk and Complex Patients

Chairs: Prof. Mutaz Al-Khnifsawi (Iraq), Prof. Pierre Sabouret (France)
13:15–13:30

From Statin Intolerance to Lipid-Lowering Tolerance: Pharmacological Design of Lifelong Cardiovascular Prevention - Insights from ILEP Recommendations.

Prof. Peter Penson · UK
13:30–13:45

Practical Recommendations 2026: Optimizing Diagnosis and Therapy for Familial Hypercholesterolemia

Prof. Richard Ceska · Czechia
13:45–14:00

ILEP 2026 Recommendations: Tailored Lipid-Lowering for Patients with Chronic Kidney Disease.

Prof. Adrian Covic · Romania
14:00–14:15 · Discussion
14:15
15:00
Lunch
15:00
16:00
Session

Upfront Combination Lipid-Lowering Therapy — A Gold Standard We Must Use to Save Patients

Chairs: Prof. Daniel Pella (Slovakia), Prof. Dragos Vinereanu (Romania)
15:00–15:15

Upfront Combination Lipid-Lowering Therapy: Rationale, ILEP Guidance, Evidence, and Clinical Impact.

Prof. Krzysztof Dyrbuś · Poland
15:15–15:30

Making Upfront (SPC) LLT the Default in High-Risk Patients: Emerging Data and the LEASH Trial.

Prof. Maciej Banach · Poland
15:30–15:45

Expanding PCSK9 Use in Primary Prevention: VESALIUS-CV Evidence and Guideline Implications

Prof. Arman Postadzhiyan · Bulgaria
15:45–16:00 · Discussion
16:00
17:00
Session

Triglycerides in CVD Prevention — Missed Marker, Neglected Atheroparticle, or Therapeutic Target?

Chairs: Prof. Žaneta Petrulionienė (Lithuania), Prof. Delia Reurean-Pintilei (Romania)
16:00–16:15

Clinical Impact of Hypertriglyceridemia: Microvascular Dysfunction, Atherosclerotic Risk, and Acute Pancreatitis.

Dr. Alexandr Ceasovschih · Romania
16:15–16:30

Managing Hypertriglyceridemia and Severe HTG (2026 US Guidelines): Clinical Recommendations and the Place of Icosapent Ethyl.

Prof. Michael D. Shapiro · ASPC, USA
16:30–16:45

ESSENCE and CORE: Olezarsen Outcomes and Where It Fits in the Hypertriglyceridemia Care Pathway.

Prof. Maciej Banach · Poland
16:45–17:00 · Discussion
17:00
17:15
Coffee Break
17:15
18:15
Session

Real-World Evidence: Successes and Pitfalls of Lipid-Lowering in Routine Practice

Chairs: Dr. Lokman H. Tanrıverdi (Turkey), Prof. Peter E. Penson (UK)
17:15–17:30

Cumulative LDL Exposure and ASCVD Prevention — Moving Beyond Single LDL-C Measurements Using Real-World Data.

Prof. Ibadete Bytyçi · Kosovo
17:30–17:45

Registry and Claims Data on PCSK9 modulators: Lessons for Clinical Practice.

Prof. Zlatko Fras · Slovenia
17:45–18:00

Acute Coronary Syndromes in Slovakia: Evolution and Future Directions in Dyslipidaemia Treatment. ILEP recommendations in practice.

Prof. Daniel Pella · Slovakia
18:00–18:15 · Discussion
18:15
19:15
Session

When Prevention Falls Short: Effectiveness of Treating Complications to Avoid Events and Death

Chairs: Prof. Adrian Covic (Romania), Prof. Branislav Vohnout (Slovakia)
18:15–18:30

Hydration and Cardiometabolic Health: How Water Intake Affects Cardiovascular Risk and Management?

Prof. Michael Henein · UK
18:30–18:45

Lipid Therapy in Heart Failure: Do Guidelines Need Changing?

Prof. Stephan von Haehling · Germany
18:45–19:00

Cardiac Rehabilitation: The Perfect Window for Preventing Subsequent Cardiovascular Events

Prof. Raimondas Kubilius · Lithuania
19:00–19:15 · Discussion
19:15
19:45
Debate

Future of CVD Prevention by 2030: Tailored Regimens, Combination Strategies, Minimalization, or Hybrid Approaches?

Moderator: Dr Yashendra Sethi (India) / Prof. Maciej Banach (Poland)
Participants
Prof. Michael D. Shapiro Prof. Prabhakaran Dorairaj Prof. Mutaz Al-Khnifsawi Prof. Handrean Soran Prof. Zlatko Fras Prof. Arrigo Cicero Prof. Stephan von Haehling Prof. Dan Gaita
19:45 · Summary of the 3rd ILEP Congress